Paragonix Technologies names Leonard A. R. Golding as CMO

Monday, June 25, 2012 11:11 AM

Paragonix Technologies, a medical device company of Cambridge, Mass., has appointed Leonard A. R. Golding, MB, BS, FRACS, FRCS(C), FACC, as chief medical officer.

Golding will be responsible for all clinical development activities related to the Paragonix’s Sherpa Cardiac Transport System. He will also immediately assume the position of chairman for the Paragonix clinical advisory board.

Golding currently serves on staff in the department of biomedical engineering at Cleveland Clinic and has a secondary appointment in the department of thoracic and cardiovascular surgery at Cleveland Clinic's main campus. He is also the project director for the NIH-funded development of a unique total artificial heart blood pump. In addition, Golding is an international speaker and has authored over 210 peer-reviewed publications.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs